Increased levels of acylation-stimulating protein in interleukin-6- deficient (IL-6-/-) mice

Endocrinology

Volumn 147, Issue 6, 2006, Pages 2690-2695

  Wernstedt, I ^a,b   Olsson, B ^a   Jernas M ^a   Paglialunga, S ^c   Carlsson, L M S ^a   Smith, U ^a   Cianflone, K ^c   Wallenius, K ^a   Wallenius, V ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPSIN; COMPLEMENT COMPONENT C3; INTERLEUKIN 6; PREALBUMIN; PROPERDIN; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GLUCOSE TRANSPORT; LIPID TRANSPORT; LIPOGENESIS; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BODY WEIGHT; COMPLEMENT C3; COMPLEMENT C3A; FATTY ACIDS, NONESTERIFIED; FEMALE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREALBUMIN; PROPERDIN; TRIGLYCERIDES;

EID: 33646788407     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-1133     Document Type: Article

References (33)

1. Pedersen BK, Steensberg A, Keller P, Keller C, Fischer C, Hiscock N, van Hall G, Plomgaard P, Febbraio MA 2003 Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects. Pflugers Arch 446:9-16
2. Wallenius K, Jansson JO, Wallenius V 2003 The therapeutic potential of interleukin-6 in treating obesity. Expert Opin Biol Ther 3:1061-1070
3. Fernandez-Real JM, Ricart W 2003 Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 24:278-301
4. Wallenius V, Wallenius K, Ahren B, Rudling M, Carlsten H, Dickson SL, Ohlsson C, Jansson JO 2002 Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8:75-79
5. Rothwell NJ, Busbridge NJ, Lefeuvre RA, Hardwick AJ, Gauldie J, Hopkins SJ 1991 Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol 69:1465-1469
6. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ 2002 Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 115:879-889
7. Wallenius K, Wallenius V, Sunter D, Dickson SL, Jansson JO 2002 Intracerebroventricular interleukin-6 treatment decreases body fat in rats. Biochem Biophys Res Commun 293:560-565
8. Stenlof K, Wernstedt I, Fjallman T, Wallenius V, Wallenius K, Jansson JO 2003 Interleukin-6 levels in the central nervous system are negatively correlated with fat mass in overweight/obese subjects. J Clin Endocrinol Metab 88:4379-4383
9. Lyngso D, Simonsen L, Bulow J 2002 Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol 543:379-386
10. Metzger S, Hassin T, Barash V, Pappo O, Chajek-Shaul T 2001 Reduced body fat and increased hepatic lipid synthesis in mice bearing interleukin-6- secreting tumor. Am J Physiol 281:E957-E965
11. Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold KR 1995 Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 136:2143-2149
12. van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK 2003 Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005-3010
13. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D 1992 Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52:4113-4116
14. Murray I, Havel PJ, Sniderman AD, Cianflone K 2000 Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 141:1041-1049
15. Xia Z, Sniderman AD, Cianflone K 2002 Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 277:45874-45879
16. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Kohler G 1994 Impaired immune and acutephase responses in interleukin-6-deficient mice. Nature 368:339-342
17. Olsson B, Bohlooly YM, Brusehed O, Isaksson OG, Ahren B, Olofsson SO, Oscarsson J, Tornell J 2003 Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes. Am J Physiol 285:E504-E511
18. Saleh J, Blevins JE, Havel PJ, Barrett JA, Gietzen DW, Cianflone K 2001 Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 25:705-713
19. Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, Yang X, Jansson PA, Smith U 2004 High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 12:454-460
20. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y 2003 Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107:671-674
21. Cianflone K, Xia Z, Chen LY 2003 Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim Biophys Acta 1609:127-143
22. Scantlebury T, Maslowska M, Cianflone K 1998 Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 273:20903-20909
23. Scantlebury T, Sniderman AD, Cianflone K 2001 Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 356:445-452
24. Kalant D, Maslowska M, Scantlebury T, Wang HW, Cianflone K 2003 Control of lipogenesis in adipose tissue and the role of acylation stimulating protein. Can J Diab 27:154-171
25. Wernstedt I, Edgley A, Berndtsson A, Faldt J, Bergstrom G, Wallenius V, Jansson JO 2 February 2006 Reduced stress- and cold-induced increase in energy expenditure in IL-6 deficient mice. Am J Physiol [Epub ahead of print: http://ajpregu.physiology.org/cgi/reprint/00514.2005v1]
26. Van Harmelen V, Reynisdottir S, Cianflone K, Degerman E, Hoffstedt J, Nilsell K, Sniderman A, Arner P 1999 Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. J Biol Chem 274:18243-18251
27. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P 2001 Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 21:1034-1039
28. Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D, Cianflone K 1999 Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 29:679-686
29. Murray I, Sniderman AD, Cianflone K 1999 Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. J Lipid Res 40:1671-1676
30. Maslowska M, Sniderman AD, Germinario R, Cianflone K 1997 ASP stimulates glucose transport in cultured human adipocytes. Int J Obes Relat Metab Disord 21:261-266
31. Klover PJ, Clementi AH, Mooney RA 2005 Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146:3417-3427
32. Rotter V, Nagaev I, Smith U 2003 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-́, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278:45777-45784
33. Weigert C, Hennige AM, Brodbeck K, Haring HU, Schleicher ED 2005 Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt. Am J Physiol 289:E251-E257